Delivery Order SPE2DB20D1050-SPE2DB24FH36K
Award Date 11/8/23
Potential Completion Date 11/9/23
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,013.38 Firm Fixed Price Delivery Order contract is for the supply of 1 GM Capsule LOVAZA, a prescription drug. The contract has no set-aside designation, indicating open competition. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award is for the delivery of Icosapent Ethyl 1 gram capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,904.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,260.58 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract was awarded without a set-aside designation and has an ultimate completion date of June 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of pharmaceutical products and medical supplies to support the DLA's mission of providing logistics, acquisition, and...
- The U.S. Defense Logistics Agency (DLA) awarded a $73,203.71 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a variety of pharmaceutical products and medical supplies. This contract, which does not have a set-aside designation, runs through January 12, 2024. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $7,357.18 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, with a completion date of February 11, 2025, is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,361.52 to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the supply of OMEGA-3 ETHYL ESTERS 1 GM CAP 120S, a pharmaceutical product, with a performance period through February 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD)...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a $7,924.38 delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. This contract, which does not have a set-aside designation, is for the provision of a variety of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. Amerisourcebergen also...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order valued at $5,202.37 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the parent company Cencora, Inc. (doing business as AmerisourceBergen). This IDC serves as a primary vehicle for the company to...
- This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth up to $1,924.56, is for delivery orders of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other essential medical supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...